Phase III Study of Monolaurin Cream Therapy for Patients With Congenital Ichthyosis - Related Studies

Phase III Study of Monolaurin Cream Therapy for Patients With Congenital Ichthyosis

This study is ongoing, but not recruiting participants.

Study NCT00004690. Last updated on June 23, 2005. Information provided by FDA Office of Orphan Products Development

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Ichthyosis

2	More general conditions related to this trial
		Congenital Abnormalities
		Infant, Newborn, Diseases
		Keratosis
		Skin Abnormalities
		Skin Diseases

3	Interventions listed in this trial
		monolaurin cream

4	Additional drug interventions recognized in this trial
		Monolaurin

5	More general drug interventions related to this trial
		Cariostatic Agents
		Pharmacologic Actions
		Physiological Effects of Drugs
		Protective Agents

6	Sponsors listed in this trial
		FDA Office of Orphan Products Development
		Cellegy Pharmaceuticals